Inflammatory breast cancer: Clinical progress and the main problems that must be addressed

doi:10.1186/bcr608

Breast Cancer Res

Volume 5
Issue 6

Viewing options:

Abstract
Full text
PDF (238KB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Giordano SH
Hortobagyi GN

on PubMed

Giordano SH
Hortobagyi GN
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

This article is part of a series on Inflammatory breast cancer, edited by Sofia Merajver.

Review

Inflammatory breast cancer: Clinical progress and the main problems that must be addressed

Sharon H Giordano and Gabriel N Hortobagyi

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

author email corresponding author email

Breast Cancer Res 2003, 5:284-288doi:10.1186/bcr608


Published:	26 August 2003

Abstract

Inflammatory breast cancer is a rare but highly aggressive form of locally advanced breast cancer. Historically, this disease was uniformly fatal; however, with the advent of induction chemotherapy and carefully coordinated multimodality treatment, the prognosis of these patients has improved. This article reviews the clinical characteristics of inflammatory breast cancer and the recent advances in therapy.